NO950813D0 - Acetamider - Google Patents
AcetamiderInfo
- Publication number
- NO950813D0 NO950813D0 NO950813A NO950813A NO950813D0 NO 950813 D0 NO950813 D0 NO 950813D0 NO 950813 A NO950813 A NO 950813A NO 950813 A NO950813 A NO 950813A NO 950813 D0 NO950813 D0 NO 950813D0
- Authority
- NO
- Norway
- Prior art keywords
- acetamides
- Prior art date
Links
- 150000003869 acetamides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4407047A DE4407047A1 (de) | 1994-03-03 | 1994-03-03 | Acetamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO950813D0 true NO950813D0 (no) | 1995-03-02 |
| NO950813L NO950813L (no) | 1995-09-04 |
Family
ID=6511754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO950813A NO950813L (no) | 1994-03-03 | 1995-03-02 | Acetamider |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5472961A (no) |
| EP (1) | EP0670318A3 (no) |
| JP (1) | JPH07267949A (no) |
| KR (1) | KR950032152A (no) |
| CN (1) | CN1121072A (no) |
| AU (1) | AU682242B2 (no) |
| CA (1) | CA2143691A1 (no) |
| CZ (1) | CZ54095A3 (no) |
| DE (1) | DE4407047A1 (no) |
| HU (1) | HUT73656A (no) |
| MX (1) | MX9501157A (no) |
| NO (1) | NO950813L (no) |
| PL (1) | PL307503A1 (no) |
| RU (1) | RU95103105A (no) |
| SK (1) | SK26995A3 (no) |
| ZA (1) | ZA951744B (no) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2422586A1 (en) * | 2000-09-15 | 2002-03-21 | The Scripps Research Institute | Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| US6992193B2 (en) | 2003-06-10 | 2006-01-31 | Adolor Corporation | Sulfonylamino phenylacetamide derivatives and methods of their use |
| JP4060247B2 (ja) * | 2003-07-14 | 2008-03-12 | 株式会社大塚製薬工場 | 薬剤容器用の口部材 |
| US20080090859A1 (en) * | 2003-10-30 | 2008-04-17 | Tioga Pharmaceuticals, Inc. | Use of Selective Opiate Receptor Modulators In the Treatment Of Neuropathy |
| KR101799429B1 (ko) * | 2010-05-03 | 2017-11-21 | 에스케이바이오팜 주식회사 | 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물 |
| KR101773331B1 (ko) * | 2012-03-05 | 2017-08-31 | 닥터 레디스 레보러터리즈 리미티드 | 카파 오피오이드 수용체(κor) 작용제인 치환된 헤테로시클릭 아세트아미드 |
| CN104364239B (zh) | 2012-06-13 | 2017-08-25 | 霍夫曼-拉罗奇有限公司 | 二氮杂螺环烷烃和氮杂螺环烷烃 |
| CA2878442A1 (en) | 2012-09-25 | 2014-04-03 | F. Hoffmann-La Roche Ag | Hexahydropyrrolo[3,4-c]pyrrole derivatives and related compounds as autotaxin (atx) inhibitors and as inhibitors of the lysophosphatidic acid (lpa) production for treating e.g. renal diseases |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| PE20160845A1 (es) | 2013-11-26 | 2016-09-10 | Hoffmann La Roche | Nuevo octahidro-ciclobuta[1,2-c;3,4-c']dipirrol-2-ilo |
| EA032357B1 (ru) | 2014-03-26 | 2019-05-31 | Ф. Хоффманн-Ля Рош Аг | Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa) |
| HUE046820T2 (hu) | 2014-03-26 | 2020-03-30 | Hoffmann La Roche | Biciklusos vegyületek autotaxin (ATX) és lizofoszfatidsav (LPA) termelésgátlókként |
| MA41179A (fr) | 2014-12-19 | 2017-10-24 | Cancer Research Tech Ltd | Composés inhibiteurs de parg |
| MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| MX377277B (es) | 2015-09-04 | 2025-03-07 | Hoffmann La Roche | Derivados de fenoximetilo. |
| RU2725138C2 (ru) | 2015-09-24 | 2020-06-30 | Ф. Хоффманн-Ля Рош Аг | Новые бициклические соединения в качестве двойных ингибиторов аутотаксина (atx)/карбоангидразы (ca) |
| BR112018006034A2 (pt) | 2015-09-24 | 2018-10-09 | Hoffmann La Roche | compostos bicíclicos como inibidores de atx |
| MA42923A (fr) | 2015-09-24 | 2021-04-28 | Hoffmann La Roche | Composés bicycliques comme inhibiteurs mixtes de atx/ca |
| WO2017050732A1 (en) | 2015-09-24 | 2017-03-30 | F. Hoffmann-La Roche Ag | Bicyclic compounds as atx inhibitors |
| CN110382484B (zh) | 2017-03-16 | 2022-12-06 | 豪夫迈·罗氏有限公司 | 新的作为atx抑制剂的二环化合物 |
| KR20190129924A (ko) | 2017-03-16 | 2019-11-20 | 에프. 호프만-라 로슈 아게 | 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 유용한 헤테로환형 화합물 |
| AU2023239344A1 (en) | 2022-03-23 | 2024-10-10 | Ideaya Biosciences, Inc. | Piperazine substituted indazole compounds as inhibitors of parg |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4192883A (en) * | 1976-04-09 | 1980-03-11 | Pierre Fabre, S.A. | Amides of pyrrolidinoethylamine which can be used in lung therapy |
| GB8618188D0 (en) * | 1986-07-25 | 1986-09-03 | Ici Plc | Diamine compounds |
| GB8827479D0 (en) * | 1988-11-24 | 1988-12-29 | Zambeletti Spa L | Novel compounds |
| DE3935371A1 (de) * | 1988-12-23 | 1990-07-05 | Merck Patent Gmbh | Stickstoffhaltige ringverbindungen |
| JPH05501551A (ja) * | 1989-11-24 | 1993-03-25 | スミスクライン ビーチャム ファルマシューティッチ エッセ ピ ア | アザ環式誘導体 |
| DE4215213A1 (de) * | 1992-05-09 | 1993-11-11 | Merck Patent Gmbh | Arylacetamide |
-
1994
- 1994-03-03 DE DE4407047A patent/DE4407047A1/de not_active Withdrawn
-
1995
- 1995-02-18 EP EP95102310A patent/EP0670318A3/de not_active Withdrawn
- 1995-02-28 AU AU13540/95A patent/AU682242B2/en not_active Ceased
- 1995-03-01 MX MX9501157A patent/MX9501157A/es unknown
- 1995-03-01 CZ CZ95540A patent/CZ54095A3/cs unknown
- 1995-03-01 SK SK269-95A patent/SK26995A3/sk unknown
- 1995-03-01 CN CN95100028A patent/CN1121072A/zh active Pending
- 1995-03-01 CA CA002143691A patent/CA2143691A1/en not_active Abandoned
- 1995-03-02 NO NO950813A patent/NO950813L/no unknown
- 1995-03-02 KR KR1019950004262A patent/KR950032152A/ko not_active Withdrawn
- 1995-03-02 ZA ZA951744A patent/ZA951744B/xx unknown
- 1995-03-02 US US08/397,758 patent/US5472961A/en not_active Expired - Fee Related
- 1995-03-02 RU RU95103105/04A patent/RU95103105A/ru unknown
- 1995-03-02 PL PL95307503A patent/PL307503A1/xx unknown
- 1995-03-03 JP JP7044587A patent/JPH07267949A/ja active Pending
- 1995-03-03 HU HU9500662A patent/HUT73656A/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR950032152A (ko) | 1995-12-20 |
| SK26995A3 (en) | 1995-10-11 |
| RU95103105A (ru) | 1997-01-10 |
| NO950813L (no) | 1995-09-04 |
| JPH07267949A (ja) | 1995-10-17 |
| CN1121072A (zh) | 1996-04-24 |
| HUT73656A (en) | 1996-09-30 |
| EP0670318A3 (de) | 1996-03-06 |
| CA2143691A1 (en) | 1995-09-04 |
| ZA951744B (en) | 1995-12-08 |
| US5472961A (en) | 1995-12-05 |
| MX9501157A (es) | 1997-02-28 |
| CZ54095A3 (en) | 1995-11-15 |
| AU682242B2 (en) | 1997-09-25 |
| AU1354095A (en) | 1995-09-14 |
| EP0670318A2 (de) | 1995-09-06 |
| DE4407047A1 (de) | 1995-09-07 |
| HU9500662D0 (en) | 1995-04-28 |
| PL307503A1 (en) | 1995-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69533099D1 (de) | Zytoanalysator | |
| ATA166795A (de) | Bis-resorcinyltriazine | |
| ATA147195A (de) | Alkoxyphenyl-substituierte bisbenzoylphosphinoxide | |
| ATA163695A (de) | 2-hydroxyphenyltriazine | |
| NO950813D0 (no) | Acetamider | |
| FI970197A0 (fi) | Kaksivaiheinen sulfaattikeittomenetelmä | |
| ATA108995A (de) | Differenzdruckakkumulator | |
| KR950033309U (ko) | 줄연장 | |
| FI944091A0 (fi) | Skyddsmask | |
| ATA11894A (de) | Stauförderbahn | |
| FI98623C (fi) | Puutavarakahmari | |
| BR7400683U (pt) | Odontoportátil | |
| SE9403034D0 (sv) | SIBAB-säkring | |
| ATE197372T1 (de) | Vorteig | |
| FI1765U1 (fi) | Moebelelement | |
| FI1651U1 (fi) | Kondensatortorkare foer livsmedel | |
| FI1451U1 (fi) | Transporterbart tillverkningsplan foer byggelement | |
| FI1428U1 (fi) | Pelarfot | |
| FI1426U1 (fi) | Branddoerr | |
| FI940253A0 (fi) | Vaextstoedslampa | |
| ATA127394A (de) | Holografischer neurochip | |
| FI941848A0 (fi) | Polerande bilvaxvante foer engaongsbruk | |
| FIU940009U0 (fi) | Soetsaksask | |
| FIU940067U0 (fi) | Matlagningsanordning | |
| FIU940088U0 (fi) | Friktionskaetting foer parhjul |